Published in Bone Marrow Transplant on December 01, 2000
Increased body mass index is associated with improved survival in United States veterans with diffuse large B-cell lymphoma. J Clin Oncol (2012) 1.17
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study. Cancer (2010) 1.12
Oncohematological diseases in the Vale do Paraíba, State of São Paulo: demographic aspects, prevalences and incidences. Rev Bras Hematol Hemoter (2011) 0.98
Risk Factors of Non-Hodgkin Lymphoma. Expert Opin Med Diagn (2011) 0.94
Body mass index, weight change, and survival in non-Hodgkin lymphoma patients in Connecticut women. Nutr Cancer (2013) 0.91
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant (2011) 0.90
Obesity and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort study. Cancer Causes Control (2014) 0.84
Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia. Biol Blood Marrow Transplant (2010) 0.83
The role of body mass index in survival outcome for lymphoma patients: US intergroup experience. Ann Oncol (2014) 0.82
Outcomes after autologous SCT in lymphoma patients grouped by weight. Bone Marrow Transplant (2015) 0.81
Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis. Bone Marrow Transplant (2013) 0.80
Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation. Blood (2014) 0.79
Autologous stem cell transplantation in hematological malignancies. Springer Semin Immunopathol (2004) 0.79
Increased body mass index is associated with improved overall survival in extranodal natural killer/T-cell lymphoma, nasal type. Oncotarget (2017) 0.75
BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications. Bone Marrow Transplant (2017) 0.75
Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant (2015) 0.75
A time to stop, a time to start: high-dose chemotherapy in overweight and obese patients. Bone Marrow Transplant (2015) 0.75
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia (2006) 5.64
B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell (1991) 3.84
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med (1997) 2.73
Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol (1987) 2.54
Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood (1994) 2.38
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia (2006) 2.38
Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J (1995) 1.94
Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet (1997) 1.94
Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood (1987) 1.77
Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology (1996) 1.74
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis. Leukemia (2005) 1.70
Childhood cancer survival in Europe. Ann Oncol (2003) 1.57
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet (1989) 1.57
Detection of hyperreactive T cells in multiple myeloma by multivalent cross-linking of the CD3/TCR complex. Blood (1991) 1.56
Eosinophilic gastroenteritis with ascites: a case report and review of the literature. Dig Dis Sci (2003) 1.51
Hodgkin's lymphoma: the pathologist's viewpoint. J Clin Pathol (2002) 1.51
Guided tissue regeneration versus mucogingival surgery in the treatment of human buccal gingival recession. J Periodontol (1992) 1.51
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia (2006) 1.51
Mesothelioma and non-occupational environmental exposure to asbestos. Lancet (1991) 1.50
Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C. Leuk Res (2011) 1.50
Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J Immunol (1994) 1.44
Detection of immunoglobulin gene rearrangement of B cell non-Hodgkin's lymphomas and leukemias in fresh, unfixed and formalin-fixed, paraffin-embedded tissue by polymerase chain reaction. Lab Invest (1993) 1.42
An analysis of which subgroups of multiple myeloma patients, divided according to b(2)-microglobulin and plasma cell labeling index, benefit from high dose vs conventional chemotherapy. Haematologica (1999) 1.39
Computed tomography findings in the first few hours of ischemic stroke: implications for the clinician. J Neurol Sci (2000) 1.38
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2005) 1.37
Occupation and bladder cancer in males: a case-control study. Int J Cancer (1985) 1.33
C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood (1992) 1.33
Spatial temporal patterns in childhood leukaemia: further evidence for an infectious origin. EUROCLUS project. Br J Cancer (1998) 1.31
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning. Leukemia (2003) 1.30
Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma. Bone Marrow Transplant (2006) 1.29
Molecular and clinical remissions in multiple myeloma: role of autologous and allogeneic transplantation of hematopoietic cells. J Clin Oncol (1999) 1.26
Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc Natl Acad Sci U S A (1991) 1.25
Progressing neurological deficit secondary to acute ischemic stroke. A study on predictability, pathogenesis, and prognosis. Arch Neurol (1995) 1.24
Asbestos and cancer: An overview of current trends in Europe. Environ Health Perspect (1999) 1.19
Changing prognosis of primary intracerebral hemorrhage: results of a clinical and computed tomographic follow-up study of 104 patients. Stroke (1988) 1.17
Long-term follow-up of metastatic renal cancer patients undergoing reduced-intensity allografting. Bone Marrow Transplant (2009) 1.15
Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry (2005) 1.14
Comparison of cerebral angiography and transcranial Doppler sonography in acute stroke. Stroke (1989) 1.14
Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci (1989) 1.14
Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health (1992) 1.12
Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy. Br J Haematol (1984) 1.12
Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma. Haematologica (2001) 1.10
Isoform-specific associations of CD45 with accessory molecules in human T lymphocytes. Eur J Immunol (1992) 1.09
Clinical and molecular characterization of Rubinstein-Taybi syndrome patients carrying distinct novel mutations of the EP300 gene. Clin Genet (2014) 1.08
Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long-term clinical follow-Up of 136 nonpreselected patients. Pediatr Cardiol (1999) 1.07
Excess of mesotheliomas after exposure to chrysotile in Balangero, Italy. Occup Environ Med (2008) 1.05
Imaging of leukocytic infiltration in human cerebral infarcts. Stroke (1985) 1.05
[Mortality from tumors and other diseases of the respiratory system in cement-asbestos workers in Casale Monferrato. A historical cohort study]. Med Lav (1988) 1.04
Childhood leukaemia in Europe after Chernobyl: 5 year follow-up. Br J Cancer (1996) 1.04
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies. J Clin Oncol (2005) 1.03
Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol. Cancer Treat Rev (1988) 1.02
Altered expression of growth-regulated protooncogenes in human malignant plasma cells. Cancer Res (1989) 1.02
Diagnosis, prognosis, and standard treatment of multiple myeloma. Hematol Oncol Clin North Am (1997) 1.01
Peripheral white blood cell count in cerebral ischemic infarction. Acta Neurol Scand (1985) 1.01
Early spontaneous improvement and deterioration of ischemic stroke patients. A serial study with transcranial Doppler ultrasonography. Stroke (1998) 1.01
Sinonasal cancer, occupation, and tobacco smoking in European women and men. Am J Ind Med (1999) 1.00
Screening for non-delta F508 mutations in five exons of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in Italy. Am J Hum Genet (1991) 1.00
Dose-intensive melphalan with stem cell support (MEL100) is superior to standard treatment in elderly myeloma patients. Blood (1999) 0.99
A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors. Leukemia (1997) 0.99
Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy. Blood (1999) 0.99
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant (2005) 0.98
Survival of breast cancer patients from Piedmont, Italy. Cancer Causes Control (1993) 0.98
Ergotamine-induced headache can be sustained by sumatriptan daily intake. Cephalalgia (1994) 0.98
Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). Eur J Epidemiol (2003) 0.98
[Consensus Conference on Pleural Mesothelioma: response of the authors]. Med Lav (2014) 0.97
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. Blood (1993) 0.97
Cancer risk among female agricultural workers: a multi-center case-control study. Am J Ind Med (1999) 0.97
Infant feeding and childhood cancer. Lancet (1988) 0.97
The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation. Eur J Clin Pharmacol (2011) 0.96
Childhood cancer survival in Europe, 1978-1992: the EUROCARE study. Eur J Cancer (2001) 0.96
Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia. Ann Hematol (1999) 0.96
Prevalence and clinical relevance of occult hepatitis B virus infection in patients on the waiting list for kidney transplantation. Transplant Proc (2009) 0.95
Childhood cancer registry of the Province of Torino, Italy. Survival, incidence, and mortality over 20 years. Cancer (1992) 0.95
Establishment and characterization of an undifferentiated human T leukemia cell line which requires granulocyte-macrophage colony stimulatory factor for growth. J Immunol (1987) 0.94
Prediction of long-term outcome in the early hours following acute ischemic stroke. Italian Acute Stroke Study Group. Arch Neurol (1995) 0.94
Cell population kinetics in human acute leukaemia. Eur J Cancer (1967) 0.94
Malignant mesothelioma of the pleura: interobserver variability. J Clin Pathol (1995) 0.93
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy. Leukemia (2004) 0.93
Acute ischemic strokes improving during the first 48 hours of onset: predictability, outcome, and possible mechanisms. A comparison with early deteriorating strokes. Stroke (1997) 0.92
Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status. Blood (1988) 0.92
Life expectancy as an indicator of outcome in follow-up of population-based cancer registries: the example of childhood leukemia. Ann Oncol (2005) 0.92
Correlation of angiographic and sequential CT findings in patients with evolving cerebral infarction. AJNR Am J Neuroradiol (1990) 0.92
Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood (1996) 0.92
Air pollution and childhood leukaemia: a nationwide case-control study in Italy. Occup Environ Med (2013) 0.92
Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking signal transducers with ecto-enzyme activities. J Immunol (1996) 0.91
Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival. Blood (1990) 0.91
Co-stimulatory signal delivered by CD73 molecule to human CD45RAhiCD45ROlo (naive) CD8+ T lymphocytes. J Immunol (1993) 0.91